Wed. 8 May 2024, 7:17am ET
Benzinga
Earnings, Earnings Beats, News
Syndax Pharmaceuticals (NASDAQ:SNDX) reported quarterly losses of $(0.85) per share which beat the analyst consensus estimate of $(0.99) by 14.14 percent. This is a 44.07 percent decrease over losses of $(0.59) per share from the same period last year.